Legend Biotech Corp (LEGN)
44.42
-0.75
(-1.66%)
USD |
NASDAQ |
Apr 25, 16:00
44.43
+0.01
(+0.02%)
Pre-Market: 20:00
Legend Biotech Shareholders Equity (Quarterly): 1.251B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.251B |
| September 30, 2023 | 1.340B |
| June 30, 2023 | 1.407B |
| March 31, 2023 | 653.16M |
| December 31, 2022 | 744.31M |
| June 30, 2022 | 562.63M |
| March 31, 2022 | 438.56M |
| December 31, 2021 | 765.94M |
| Date | Value |
|---|---|
| September 30, 2021 | 225.87M |
| June 30, 2021 | 339.92M |
| March 31, 2021 | 206.45M |
| December 31, 2020 | 597.77M |
| September 30, 2020 | 334.90M |
| June 30, 2020 | 401.00M |
| March 31, 2020 | -15.88M |
| December 31, 2019 | -122.87M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-122.87M
Minimum
Dec 2019
1.407B
Maximum
Jun 2023
570.61M
Average
500.60M
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 68.77B |
| Bristol-Myers Squibb Co | 29.43B |
| 2seventy bio Inc | 255.30M |
| Gilead Sciences Inc | 22.83B |
| Exelixis Inc | 2.264B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.849B |
| Total Liabilities (Quarterly) | 597.24M |
| Debt to Equity Ratio | 0.2248 |
| Current Ratio | 6.921 |
| Net Debt Paydown Yield | -0.51% |